Treatment of multiple sclerosis and other autoimmune diseases with cladribine

Semin Hematol. 1996 Jan;33(1 Suppl 1):45-52.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Analysis of Variance
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / pathology
  • Cladribine / adverse effects
  • Cladribine / therapeutic use*
  • Cross-Over Studies
  • Double-Blind Method
  • Follow-Up Studies
  • Hematologic Tests
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Magnetic Resonance Imaging
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / pathology
  • Neurologic Examination
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy

Substances

  • Immunosuppressive Agents
  • Cladribine